179 related articles for article (PubMed ID: 30282895)
21. 1H NMR-based metabonomic and pattern recognition analysis for detection of oral squamous cell carcinoma.
Zhou J; Xu B; Huang J; Jia X; Xue J; Shi X; Xiao L; Li W
Clin Chim Acta; 2009 Mar; 401(1-2):8-13. PubMed ID: 19056370
[TBL] [Abstract][Full Text] [Related]
22. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
23. [Identification of serum biomarkers and evaluation of metabolism disorders in patients with oral squamous cell carcinoma].
Li XB; Liu LW; Li N; Jia QQ; Wang XS; Long JL; Xue P; Sun Z; Zhao HY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Sep; 56(9):926-932. PubMed ID: 34496544
[No Abstract] [Full Text] [Related]
24. Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma.
Ding L; Li B; Zhao Y; Fu YF; Hu EL; Hu QG; Ni YH; Hou YY
Tumour Biol; 2014 Oct; 35(10):10539-46. PubMed ID: 25060177
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Serum Fucose Levels in Leukoplakia and Oral Cancer Patients.
Rai NP; Anekar J; Shivaraja Shankara YM; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Sebastian R; Raj AC; Al-Hazmi A; Mustafa SM
Asian Pac J Cancer Prev; 2015; 16(17):7497-500. PubMed ID: 26625751
[TBL] [Abstract][Full Text] [Related]
26. Salivaomics in oral cancer.
Aro K; Kaczor-Urbanowicz K; Carreras-Presas CM
Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):91-97. PubMed ID: 30507690
[TBL] [Abstract][Full Text] [Related]
27. Plasma Levels of Endothelial Cell-Specific Molecule-1 as a Potential Biomarker of Oral Cancer Progression.
Yang WE; Hsieh MJ; Lin CW; Kuo CY; Yang SF; Chuang CY; Chen MK
Int J Med Sci; 2017; 14(11):1094-1100. PubMed ID: 29104463
[TBL] [Abstract][Full Text] [Related]
28. ¹H NMR-derived serum metabolomics of leukoplakia and squamous cell carcinoma.
Gupta A; Gupta S; Mahdi AA
Clin Chim Acta; 2015 Feb; 441():47-55. PubMed ID: 25499120
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma.
Srisuttee R; Arayataweegool A; Mahattanasakul P; Tangjaturonrasme N; Kerekhanjanarong V; Keelawat S; Mutirangura A; Kitkumthorn N
BMC Cancer; 2020 Mar; 20(1):218. PubMed ID: 32171289
[TBL] [Abstract][Full Text] [Related]
30. Identification of salivary metabolites for oral squamous cell carcinoma and oral epithelial dysplasia screening from persistent suspicious oral mucosal lesions.
Ishikawa S; Wong DTW; Sugimoto M; Gleber-Netto FO; Li F; Tu M; Zhang Y; Akin D; Iino M
Clin Oral Investig; 2019 Sep; 23(9):3557-3563. PubMed ID: 30539290
[TBL] [Abstract][Full Text] [Related]
31. Identification of SCARA5 as a Potential Biomarker for Oral Squamous Cell Carcinoma using MALDI-TOF-MS Analysis.
Liu Y; Tan YR; Sun WW; Ju WT; Fu Y; Wang LZ; Li J; Zhang CP; Zhang ZY; Zhong LP
Proteomics Clin Appl; 2018 Sep; 12(5):e1700180. PubMed ID: 29461673
[TBL] [Abstract][Full Text] [Related]
32. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
[TBL] [Abstract][Full Text] [Related]
33. Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression.
Su CW; Su BF; Chiang WL; Yang SF; Chen MK; Lin CW
Int J Med Sci; 2017; 14(1):37-44. PubMed ID: 28138307
[TBL] [Abstract][Full Text] [Related]
34. Measurement of salivary metabolite biomarkers for early monitoring of oral cancer with ultra performance liquid chromatography-mass spectrometry.
Wang Q; Gao P; Cheng F; Wang X; Duan Y
Talanta; 2014 Feb; 119():299-305. PubMed ID: 24401418
[TBL] [Abstract][Full Text] [Related]
35. The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics.
Wang Q; Gao P; Wang X; Duan Y
Sci Rep; 2014 Oct; 4():6802. PubMed ID: 25354816
[TBL] [Abstract][Full Text] [Related]
36. Oral squamous cell carcinoma diagnosed from saliva metabolic profiling.
Song X; Yang X; Narayanan R; Shankar V; Ethiraj S; Wang X; Duan N; Ni YH; Hu Q; Zare RN
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16167-16173. PubMed ID: 32601197
[TBL] [Abstract][Full Text] [Related]
37. Integrated analyses utilizing metabolomics and transcriptomics reveal perturbation of the polyamine pathway in oral cavity squamous cell carcinoma.
Hsu CW; Chen YT; Hsieh YJ; Chang KP; Hsueh PC; Chen TW; Yu JS; Chang YS; Li L; Wu CC
Anal Chim Acta; 2019 Mar; 1050():113-122. PubMed ID: 30661578
[TBL] [Abstract][Full Text] [Related]
38. An immuno-MALDI mass spectrometry assay for the oral cancer biomarker, matrix metalloproteinase-1, in dried saliva spot samples.
Hsiao YC; Lin SY; Chien KY; Chen SF; Wu CC; Chang YT; Chi LM; Chu LJ; Chiang WF; Chien CY; Chang KP; Chang YS; Yu JS
Anal Chim Acta; 2020 Mar; 1100():118-130. PubMed ID: 31987131
[TBL] [Abstract][Full Text] [Related]
39. Proteomic diagnosis models from serum for early detection of oral squamous cell carcinoma.
Sun G; He H; Ping F; Zhang F
Artif Cells Blood Substit Immobil Biotechnol; 2009; 37(3):125-9. PubMed ID: 19412825
[TBL] [Abstract][Full Text] [Related]
40. High Level of Plasma EGFL6 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma.
Chuang CY; Chen MK; Hsieh MJ; Yeh CM; Lin CW; Yang WE; Yang SF; Chou YE
Int J Med Sci; 2017; 14(5):419-424. PubMed ID: 28539817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
